Choose from our industry specialties


Get more qualified clients using Facebook

The Numbers don't lie

Live up to date stat reporting for going Truvada rates (Sept 1 - Sept 30, 2020)

Gilead is accused of knowing that Truvada could cause serious side effects, but allegedly withheld a safer version of the medication, tenofovir alafenamide fumarate (TAF).

Despite evidence that TAF was safer, the drugmaker delayed clinical research for several years, resuming when its patent on Truvada was expiring. Critics says the company purposefully delayed TAF research in order to prolong its patent on tenofovir-containing drugs and safeguard its market dominance until 2032.

Meanwhile, nearly 20,000 people with HIV were allegedly diagnosed with kidney disease and nearly 6,000 bone breaks are alleged to be linked to the TDF-based antiretroviral drugs. Gilead paid doctors across the country to give TAF to patients in small clinical trials. The positive results of those studies were not published for years. “Their secrecy”, the lawsuits said “was an act of extreme malice.”

Gilead received FDA Truvada warning letters on two occasions when drug company representatives were caught downplaying Truvada side effects and making false claims about the drug’s safety.

Get Started


Our Goal is to see you succeed. Read what our clients have to say about the X Social Media experience.

Contact Us

Call us (888) 670-0006 or email us on the online form

    © 2022 X Social Media All rights reserved